This analysis examines the historical and forecast performance for Ipsen in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Scope

Highlights

Reasons to Purchase

Benchmark Ipsen's performance against key rivals in the ethical pharmaceutical sector Determine how Ipsen will perform over the period 2006-11 having recently become a publicly run company Assess Ipsen's biologic capabilities, which will play a key role in the company's sales growth performance out to 2011